David Campbell was appointed President and CEO of Janux Therapeutics, Inc. on July 25, 2025.
1 report, 1 independent
Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
David Campbell was appointed President and CEO of Janux Therapeutics, Inc. on July 25, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
David Campbell
researcher (ORCID 0000-0002-5129-0007)
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireJanux Therapeutics Highlights Pipeline Progress and Best-in-Class Potential of Novel Bispecific Platform for Autoimmune Diseases at Virtual R&D Day PSMA-TRACIr designed to be combined with potentiall